[Fulminant meningococcemia treated with antiendotoxin IgM monoclonal antibodies (HA-1A)].
Gómez-Jiménez
J
J
Peracaula Picart
R
R
Jódar Masanes
R
R
Montoro Ronsano
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016470:Bacteremia / Q000188:drug therapy*; D004731:Endotoxins / Q000276:immunology*; D005260:Female; D006801:Humans; D008589:Meningococcal Infections / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins; C068069:nebacumab
Meningococemia fulminante tratada con anticuerpos monoclonales IgM antiendotoxina (HA-1A).